Clinical Trial Update: The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating Ammoxetine Hydrochloride Enteric-coated Tablets for major depressive disorder is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ammoxetine Hydrochloride Enteric-coated Tablets (ammoxetine hydrochloride)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Major Depressive Disorder (MDD) | Phase 3 | Status: NOT_YET_RECRUITING